Contract 75N91022F00002
Westat, Inc. · Department Of Health And Human Services · July 12, 2024
Westat, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 12, 2024 for $5.50 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Rockville, MD. This is a task or delivery order issued under parent IDIQ 75N91022D00009. It was awarded under full and open competition. The contract has been modified 11 times since the base award It uses cost-plus contract pricing. The most recent modification was on June 12, 2026. If all options are exercised, the contract could reach $12.30 million.
Contract details
- PIID
- 75N91022F00002
- Parent IDIQ
- 75N91022D00009
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Rockville, MD
- First action
- July 12, 2024
- Latest action
- June 12, 2026
Description
TASK ORDER 4A SITE STUDY SETUP: CANCER TRIALS SUPPORT UNIT (CTSU) IDIQ
Modification timeline
-
June 12, 2026Mod P00005 · Exercise An Option$7.55M
-
February 11, 2026Mod P00008 · Change OrderDEVELOPMENT, PRODUCTION, AND DISSEMINATION OF NCI TOBACCO CONTROL MONOGRAPH$1.51M
-
January 13, 2026Mod P00003 · Supplemental Agreement For Work Within ScopeTITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE$1.44M
-
November 24, 2025Mod P00006 · Supplemental Agreement For Work Within ScopeBASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREV…$1.24M
-
July 18, 2025Mod P00003 · Exercise An OptionPROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)$4.70M
-
July 14, 2025Mod P00005 · Supplemental Agreement For Work Within ScopeBASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREV…$1.24M
-
July 14, 2025Mod P00004 · Exercise An OptionNUCLEIC ACID EXTRACTIONS FOR DCEG STUDIES$631.5K
-
September 11, 2024Mod P00002 · Exercise An OptionPURPOSE OF MODIFICATION 1)EXERCISE AND FULLY FUND OPTION 2; 2)DE-OBLIGATE FROM BASE, OPTIONS/OPTIONAL TASKS BOTH THE SAMPLE SIZE AND FUNDED AMOUNTS; 3)UPDATE ARTICLES B.2., F.1., G.4., AND H.2.$1.39M
-
August 27, 2024Mod P00002 · Supplemental Agreement For Work Within ScopeSUPPORT SERVICES, CONTRACT SPECIALIST 1 FOR TSB, OA$295.5K
-
August 6, 2024Mod P00003 · Exercise An OptionNUCLEIC ACID EXTRACTIONS FOR DCEG STUDIES$578.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $77.58M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $8.41M |
| Technical Resources International, Inc. | Department Of Health And Human Services | July 2, 2026 | $39.32M |
| Consolidated Safety Services Incorporated | Department Of Health And Human Services | July 2, 2026 | $465.3K |
| University Of Mississippi Medical Center | Department Of Health And Human Services | July 2, 2026 | $0 |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $10.12M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91022F00002?
Contract 75N91022F00002 is a federal contract awarded to Westat, Inc. by Department Of Health And Human Services on July 12, 2024 for $5.50 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 11 times since the base award.
Who won contract 75N91022F00002?
Westat, Inc. won contract 75N91022F00002 from Department Of Health And Human Services.
How much is contract 75N91022F00002 worth?
Contract 75N91022F00002 has obligated $5.50 million to date, with a total potential value of $12.30 million if all options are exercised.